Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-15 1:09 pm Sale | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | LYTTON LAURENCE W | 85,416 2.500% | -81,604 (-48.86%) | Filing History |
| 2022-02-14 4:48 pm Sale | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Omega Fund V L.P. | 62,500 1.800% | -100,262 (-61.60%) | Filing History |
| 2022-02-14 4:41 pm Purchase | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 215,902 6.500% | 5,902 (+2.81%) | Filing History |
| 2022-02-14 08:30 am Purchase | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Nantahala Capital Management, LLC | 263,523 7.900% | 263,523 (New Position) | Filing History |
| 2022-02-11 4:48 pm Sale | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | BB BIOTECH AG | 0 0.000% | -141,125 (Position Closed) | Filing History |
| 2021-12-16 5:16 pm Purchase | 2021-12-14 | 13G | Cidara Therapeutics, Inc. CDTX | BIOTECHNOLOGY VALUE FUND L P | 343,056 10.300% | 119,982 (+53.79%) | Filing History |
| 2021-10-14 5:12 pm Purchase | 2021-10-13 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 210,000 6.300% | 210,000 (New Position) | Filing History |
| 2021-08-11 7:27 pm Sale | 2021-08-03 | 13D | Cidara Therapeutics, Inc. CDTX | INTERWEST PARTNERS X LP | 45,187 1.900% | -22,654 (-33.39%) | Filing History |
| 2021-03-05 7:26 pm Purchase | 2021-02-25 | 13G | Cidara Therapeutics, Inc. CDTX | LYTTON LAURENCE W | 167,020 7.000% | 30,666 (+22.49%) | Filing History |
| 2021-03-05 4:55 pm Purchase | 2021-02-25 | 13G | Cidara Therapeutics, Inc. CDTX | LYTTON LAURENCE W | 136,354 5.700% | 136,354 (New Position) | Filing History |
| 2021-02-16 11:39 am Sale | 2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | 5AM VENTURES III L.P. | 100,326 4.600% | -450 (-0.45%) | Filing History |
| 2021-02-12 5:01 pm Sale | 2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Stonepine Capital Management, LLC | 0 0.000% | -102,702 (Position Closed) | Filing History |
| 2021-02-12 4:17 pm Purchase | 2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | BB BIOTECH AG | 141,125 6.400% | 26,361 (+22.97%) | Filing History |
| 2021-02-12 4:06 pm Purchase | 2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | BIOTECHNOLOGY VALUE FUND L P | 223,075 9.990% | 54,637 (+32.44%) | Filing History |
| 2021-02-12 1:51 pm Purchase | 2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Omega Fund V L.P. | 162,762 7.200% | 18,237 (+12.62%) | Filing History |